Trial Outcomes & Findings for Education About Health and Cancer Study (NCT NCT04409782)
NCT ID: NCT04409782
Last Updated: 2026-06-30
Results Overview
A pre-test and post-test knowledge questionnaire conducted with participants to assess changes in knowledge related to key learning outcomes expected from the educational intervention, assessed via percent of correct and incorrect responses to 11 true/false "knowledge" questions. A large positive number indicates the percent increase in people getting the answer right after the intervention. % change is a unique number that was calculated as the difference between the % answering correctly after the intervention minus the % correct before the intervention; it is representative of the entire data set and not calculated on an individual participant level. Each row represents a unique survey question evaluating the topic listed in the row title.
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
260 participants
Primary outcome timeframe
Pre-test questionnaire administered before educational intervention; post-test questionnaire administered after educational intervention on same day. Number represents change in knowledge (increase in % of respondents getting the answer correct).
Results posted on
2026-06-30
Participant Flow
Participant milestones
| Measure |
Arm 1
People with social medial accounts (e.g. Facebook) will receive a message about the study (e.g. via a geospatially targeted Facebook ad) and have the option to enroll in the study if meeting eligibility criteria, with some participating in online follow-up.
Online educational video: Participants will receive online education via a video and written web content. Key messages will include information pertaining to cancer research studies and clinical trials. Data will be collected via pre- and post-tests. The post-test includes questions to pre-screen participants for eligibility into cancer research studies and clinical trials; as appropriate, study participants will be referred to those study/trial/clinical teams for follow-up.
|
|---|---|
|
Overall Study
STARTED
|
260
|
|
Overall Study
COMPLETED
|
260
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Education About Health and Cancer Study
Baseline characteristics by cohort
| Measure |
Arm 1
n=260 Participants
People with social medial accounts (e.g. Facebook) will receive a message about the study (e.g. via a geospatially targeted Facebook ad) and have the option to enroll in the study if meeting eligibility criteria, with some participating in online follow-up.
Online educational video: Participants will receive online education via a video and written web content. Key messages will include information pertaining to cancer research studies and clinical trials. Data will be collected via pre- and post-tests. The post-test includes questions to pre-screen participants for eligibility into cancer research studies and clinical trials; as appropriate, study participants will be referred to those study/trial/clinical teams for follow-up.
|
|---|---|
|
Age, Continuous
|
58.1 years
STANDARD_DEVIATION 14.5 • n=20 Participants
|
|
Sex/Gender, Customized
Female
|
220 Participants
n=20 Participants
|
|
Sex/Gender, Customized
Male
|
36 Participants
n=20 Participants
|
|
Sex/Gender, Customized
Other/Missing
|
4 Participants
n=20 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
6 Participants
n=20 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
254 Participants
n=20 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=20 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=20 Participants
|
|
Race (NIH/OMB)
Asian
|
3 Participants
n=20 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=20 Participants
|
|
Race (NIH/OMB)
Black or African American
|
2 Participants
n=20 Participants
|
|
Race (NIH/OMB)
White
|
255 Participants
n=20 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=20 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=20 Participants
|
|
Region of Enrollment
United States
|
260 participants
n=20 Participants
|
|
Education High School
|
18 Participants
n=20 Participants
|
|
Education Some College
|
36 Participants
n=20 Participants
|
|
Education College graduate
|
206 Participants
n=20 Participants
|
PRIMARY outcome
Timeframe: Pre-test questionnaire administered before educational intervention; post-test questionnaire administered after educational intervention on same day. Number represents change in knowledge (increase in % of respondents getting the answer correct).Population: All participants
A pre-test and post-test knowledge questionnaire conducted with participants to assess changes in knowledge related to key learning outcomes expected from the educational intervention, assessed via percent of correct and incorrect responses to 11 true/false "knowledge" questions. A large positive number indicates the percent increase in people getting the answer right after the intervention. % change is a unique number that was calculated as the difference between the % answering correctly after the intervention minus the % correct before the intervention; it is representative of the entire data set and not calculated on an individual participant level. Each row represents a unique survey question evaluating the topic listed in the row title.
Outcome measures
| Measure |
Arm 1
n=260 Participants
People with social medial accounts (e.g. Facebook) will receive a message about the study (e.g. via a geospatially targeted Facebook ad) and have the option to enroll in the study if meeting eligibility criteria, with some participating in online follow-up.
Online educational video: Participants will receive online education via a video and written web content. Key messages will include information pertaining to cancer research studies and clinical trials. Data will be collected via pre- and post-tests. The post-test includes questions to pre-screen participants for eligibility into cancer research studies and clinical trials; as appropriate, study participants will be referred to those study/trial/clinical teams for follow-up.
|
Experimental Arm Post Education
People with social medial accounts (e.g. Facebook) will receive a message about the study (e.g. via a geospatially targeted Facebook ad) and have the option to enroll in the study if meeting eligibility criteria, with some participating in online follow-up.
Online educational video: Participants will receive online education via a video and written web content. Key messages will include information pertaining to cancer research studies and clinical trials. Data will be collected via pre- and post-tests. The post-test includes questions to pre-screen participants for eligibility into cancer research studies and clinical trials; as appropriate, study participants will be referred to those study/trial/clinical teams for follow-up.
|
|---|---|---|
|
Change in % of Participants With Correct Knowledge Related to What Cancer Research Studies and Clinical Trials Are as Assessed Before and After Educational Intervention, Measured on the Same Day
A clinical trial can test a new medicine or treatment to see if it is safe
|
3.8 Change in %
|
—
|
|
Change in % of Participants With Correct Knowledge Related to What Cancer Research Studies and Clinical Trials Are as Assessed Before and After Educational Intervention, Measured on the Same Day
The consent form explains the known risks of being in the clinical trial
|
-0.4 Change in %
|
—
|
|
Change in % of Participants With Correct Knowledge Related to What Cancer Research Studies and Clinical Trials Are as Assessed Before and After Educational Intervention, Measured on the Same Day
Trials of new medicines/treatments are carefully reviewed for safety by experts & community members
|
4.6 Change in %
|
—
|
|
Change in % of Participants With Correct Knowledge Related to What Cancer Research Studies and Clinical Trials Are as Assessed Before and After Educational Intervention, Measured on the Same Day
Clinical trials test whether a new medicine or treatment works
|
1.9 Change in %
|
—
|
|
Change in % of Participants With Correct Knowledge Related to What Cancer Research Studies and Clinical Trials Are as Assessed Before and After Educational Intervention, Measured on the Same Day
Clinical trials help decide which doses of a medicine are best
|
6.5 Change in %
|
—
|
|
Change in % of Participants With Correct Knowledge Related to What Cancer Research Studies and Clinical Trials Are as Assessed Before and After Educational Intervention, Measured on the Same Day
A possible benefit of participating in a clinical trial is getting new & possibly better treatments
|
2.7 Change in %
|
—
|
|
Change in % of Participants With Correct Knowledge Related to What Cancer Research Studies and Clinical Trials Are as Assessed Before and After Educational Intervention, Measured on the Same Day
In a clinical trial, a patient will always get the new medicine or treatment being tested
|
2.3 Change in %
|
—
|
|
Change in % of Participants With Correct Knowledge Related to What Cancer Research Studies and Clinical Trials Are as Assessed Before and After Educational Intervention, Measured on the Same Day
Once I sign a consent form, I must stay in the clinical trial until my doctor tells me I'm done.
|
5.0 Change in %
|
—
|
|
Change in % of Participants With Correct Knowledge Related to What Cancer Research Studies and Clinical Trials Are as Assessed Before and After Educational Intervention, Measured on the Same Day
Any medicine will have the same effect for all persons regardless of race or ethnicity
|
2.3 Change in %
|
—
|
|
Change in % of Participants With Correct Knowledge Related to What Cancer Research Studies and Clinical Trials Are as Assessed Before and After Educational Intervention, Measured on the Same Day
You can only join a clinical trial after you have tried all other options
|
3.1 Change in %
|
—
|
|
Change in % of Participants With Correct Knowledge Related to What Cancer Research Studies and Clinical Trials Are as Assessed Before and After Educational Intervention, Measured on the Same Day
All possible side effects of a new medicine being tested are known before the clinical trial starts
|
1.2 Change in %
|
—
|
PRIMARY outcome
Timeframe: Pre-test questionnaire administered before educational intervention; post-test questionnaire administered after educational intervention on same dayPopulation: All participants
A pre-test and post-test questionnaire conducted with participants to assess any changes in attitudes and behavioral intentions related to clinical trial enrollment (assessed via 5 Likert-scale questions: 1 Strongly disagree, 2 Disagree, 3 Unsure, 4 Agree, 5 Strongly agree). The values reported are the mean scores of pre-intervention and post-intervention scores both measured on the same day. Each row represents a unique survey question evaluating the topic listed in the row title.
Outcome measures
| Measure |
Arm 1
n=260 Participants
People with social medial accounts (e.g. Facebook) will receive a message about the study (e.g. via a geospatially targeted Facebook ad) and have the option to enroll in the study if meeting eligibility criteria, with some participating in online follow-up.
Online educational video: Participants will receive online education via a video and written web content. Key messages will include information pertaining to cancer research studies and clinical trials. Data will be collected via pre- and post-tests. The post-test includes questions to pre-screen participants for eligibility into cancer research studies and clinical trials; as appropriate, study participants will be referred to those study/trial/clinical teams for follow-up.
|
Experimental Arm Post Education
n=260 Participants
People with social medial accounts (e.g. Facebook) will receive a message about the study (e.g. via a geospatially targeted Facebook ad) and have the option to enroll in the study if meeting eligibility criteria, with some participating in online follow-up.
Online educational video: Participants will receive online education via a video and written web content. Key messages will include information pertaining to cancer research studies and clinical trials. Data will be collected via pre- and post-tests. The post-test includes questions to pre-screen participants for eligibility into cancer research studies and clinical trials; as appropriate, study participants will be referred to those study/trial/clinical teams for follow-up.
|
|---|---|---|
|
Mean Change in Intent to Enroll in Clinical Trials
am likely to search for a clinical trial that I might be eligible for
|
3.5 score on a scale
Standard Deviation 1.0
|
3.8 score on a scale
Standard Deviation 1.0
|
|
Mean Change in Intent to Enroll in Clinical Trials
It is important for minority groups to participate in clinical trials
|
4.4 score on a scale
Standard Deviation 0.8
|
4.6 score on a scale
Standard Deviation 0.6
|
|
Mean Change in Intent to Enroll in Clinical Trials
I'd consider talking to my doctor/health care provider about clinical trials that are right for me
|
4.2 score on a scale
Standard Deviation .8
|
4.3 score on a scale
Standard Deviation 0.8
|
|
Mean Change in Intent to Enroll in Clinical Trials
I am likely to join a clinical trial
|
3.8 score on a scale
Standard Deviation 0.8
|
3.9 score on a scale
Standard Deviation 0.8
|
|
Mean Change in Intent to Enroll in Clinical Trials
I am likely to talk to family/friends about joining a clinical trial
|
3.8 score on a scale
Standard Deviation 1.0
|
4.0 score on a scale
Standard Deviation 0.9
|
|
Mean Change in Intent to Enroll in Clinical Trials
I am likely to seek out information regarding clinical trials
|
3.8 score on a scale
Standard Deviation 1.0
|
3.9 score on a scale
Standard Deviation 0.9
|
PRIMARY outcome
Timeframe: From time of study participation in educational intervention up to six months.Population: Participants who enrolled in a trial within 6 months after the intervention.
Actual enrollment into a clinical trial or cancer research study will be assessed via Dartmouth Cancer Center (DCC) Office of Clinical Research enrollment records over 6 months post-intervention, measured as a change from the baseline value of 0 participants. Enrollment records for specified DCC trials/research studies will also be assessed and change in enrollment status in cancer research or clinical trials will be measured by direct participant's active status in cancer research or clinical trials project participation.
Outcome measures
| Measure |
Arm 1
n=233 Participants
People with social medial accounts (e.g. Facebook) will receive a message about the study (e.g. via a geospatially targeted Facebook ad) and have the option to enroll in the study if meeting eligibility criteria, with some participating in online follow-up.
Online educational video: Participants will receive online education via a video and written web content. Key messages will include information pertaining to cancer research studies and clinical trials. Data will be collected via pre- and post-tests. The post-test includes questions to pre-screen participants for eligibility into cancer research studies and clinical trials; as appropriate, study participants will be referred to those study/trial/clinical teams for follow-up.
|
Experimental Arm Post Education
People with social medial accounts (e.g. Facebook) will receive a message about the study (e.g. via a geospatially targeted Facebook ad) and have the option to enroll in the study if meeting eligibility criteria, with some participating in online follow-up.
Online educational video: Participants will receive online education via a video and written web content. Key messages will include information pertaining to cancer research studies and clinical trials. Data will be collected via pre- and post-tests. The post-test includes questions to pre-screen participants for eligibility into cancer research studies and clinical trials; as appropriate, study participants will be referred to those study/trial/clinical teams for follow-up.
|
|---|---|---|
|
Change in Enrollment Status in Cancer Research Studies and Clinical Trials as Measured by Comparing Individual % Enrolled at the Time of Intervention and % Who Have Enrolled Within 6 Months After the Intervention
|
23.6 Change in % enrolled
|
—
|
Adverse Events
Intervention
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place